These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38113697)

  • 1. Novel Homozygous Variants of SLC13A5 Expand the Functional Heterogeneity of a Homogeneous Syndrome of Early Infantile Epileptic Encephalopathy.
    Alsemari A; Guzmán-Vega FJ; Meyer BF; Arold ST
    Pediatr Neurol; 2024 Feb; 151():68-72. PubMed ID: 38113697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.
    Hardies K; de Kovel CG; Weckhuysen S; Asselbergh B; Geuens T; Deconinck T; Azmi A; May P; Brilstra E; Becker F; Barisic N; Craiu D; Braun KP; Lal D; Thiele H; Schubert J; Weber Y; van 't Slot R; Nürnberg P; Balling R; Timmerman V; Lerche H; Maudsley S; Helbig I; Suls A; Koeleman BP; De Jonghe P;
    Brain; 2015 Nov; 138(Pt 11):3238-50. PubMed ID: 26384929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.
    Bhutia YD; Kopel JJ; Lawrence JJ; Neugebauer V; Ganapathy V
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal developmental and epileptic encephalopathy due to autosomal recessive variants in SLC13A5 gene.
    Matricardi S; De Liso P; Freri E; Costa P; Castellotti B; Magri S; Gellera C; Granata T; Musante L; Lesca G; Oertel J; Craiu D; Hammer TB; Møller RS; Barisic N; Abou Jamra R; Polster T; Vigevano F; Marini C
    Epilepsia; 2020 Nov; 61(11):2474-2485. PubMed ID: 33063863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC13A5 is the second gene associated with Kohlschütter-Tönz syndrome.
    Schossig A; Bloch-Zupan A; Lussi A; Wolf NI; Raskin S; Cohen M; Giuliano F; Jurgens J; Krabichler B; Koolen DA; de Macena Sobreira NL; Maurer E; Muller-Bolla M; Penzien J; Zschocke J; Kapferer-Seebacher I
    J Med Genet; 2017 Jan; 54(1):54-62. PubMed ID: 27600704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood-brain barrier.
    Kopel JJ; Bhutia YD; Sivaprakasam S; Ganapathy V
    Biochem J; 2021 Feb; 478(3):463-486. PubMed ID: 33544126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy.
    Goodspeed K; Liu JS; Nye KL; Prasad S; Sadhu C; Tavakkoli F; Bilder DA; Minassian BA; Bailey RM
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Punctate white matter lesions in full-term infants with neonatal seizures associated with SLC13A5 mutations.
    Weeke LC; Brilstra E; Braun KP; Zonneveld-Huijssoon E; Salomons GS; Koeleman BP; van Gassen KL; van Straaten HL; Craiu D; de Vries LS
    Eur J Paediatr Neurol; 2017 Mar; 21(2):396-403. PubMed ID: 27913086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.
    Kopel J; Grooms A; Ganapathy V; Clothier J
    Psychiatr Genet; 2021 Feb; 31(1):32-35. PubMed ID: 33290383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life.
    Thevenon J; Milh M; Feillet F; St-Onge J; Duffourd Y; Jugé C; Roubertie A; Héron D; Mignot C; Raffo E; Isidor B; Wahlen S; Sanlaville D; Villeneuve N; Darmency-Stamboul V; Toutain A; Lefebvre M; Chouchane M; Huet F; Lafon A; de Saint Martin A; Lesca G; El Chehadeh S; Thauvin-Robinet C; Masurel-Paulet A; Odent S; Villard L; Philippe C; Faivre L; Rivière JB
    Am J Hum Genet; 2014 Jul; 95(1):113-20. PubMed ID: 24995870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel homozygous SLC13A5 whole-gene deletion generated by Alu/Alu-mediated rearrangement in an Iraqi family with epileptic encephalopathy.
    Duan R; Saadi NW; Grochowski CM; Bhadila G; Faridoun A; Mitani T; Du H; Fatih JM; Jhangiani SN; Akdemir ZC; Gibbs RA; Pehlivan D; Posey JE; Marafi D; Lupski JR
    Am J Med Genet A; 2021 Jul; 185(7):1972-1980. PubMed ID: 33797191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle.
    Bainbridge MN; Cooney E; Miller M; Kennedy AD; Wulff JE; Donti T; Jhangiani SN; Gibbs RA; Elsea SH; Porter BE; Graham BH
    Mol Genet Metab; 2017 Aug; 121(4):314-319. PubMed ID: 28673551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroimaging spectrum of SLC13A5 related developmental and epileptic encephalopathy.
    Whitney R; Choi E; Jones KC
    Seizure; 2023 Mar; 106():8-13. PubMed ID: 36701889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MED13 mutation: A novel cause of developmental and epileptic encephalopathy with infantile spasms.
    Trivisano M; De Dominicis A; Micalizzi A; Ferretti A; Dentici ML; Terracciano A; Calabrese C; Vigevano F; Novelli G; Novelli A; Specchio N
    Seizure; 2022 Oct; 101():211-217. PubMed ID: 36087421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. West syndrome, developmental and epileptic encephalopathy, and severe CNS disorder associated with WWOX mutations.
    Shaukat Q; Hertecant J; El-Hattab AW; Ali BR; Suleiman J
    Epileptic Disord; 2018 Oct; 20(5):401-412. PubMed ID: 30361190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel patients with epileptic encephalopathy due to biallelic mutations in the PLCB1 gene.
    Desprairies C; Valence S; Maurey H; Helal SI; Weckhuysen S; Soliman H; Mefford HC; Spentchian M; Héron D; Leguern E; Nava C; Bouilleret V; Moretti R; Mignot C
    Clin Genet; 2020 Mar; 97(3):477-482. PubMed ID: 31883110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and genetic characteristics of children with STXBP1 encephalopathy].
    Cao JJ; Ji XN; Mao YY; Zhang PP; Liu WT; Zhang HZ; Ding N; Chen Q
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):493-498. PubMed ID: 32521962
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbamazepine efficacy in a severe electro-clinical presentation of SLC13A5-epilepsy.
    Santalucia R; Vilain C; Soblet J; De Laet C; Vuckovic A; König J; Aeby A
    Ann Clin Transl Neurol; 2022 Jul; 9(7):1095-1099. PubMed ID: 35633140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
    Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult phenotype of the homozygous missense mutation c.655G>A, p.Gly219Arg in SLC13A5: A case report.
    Arvio M; Lähdetie J
    Am J Med Genet A; 2020 Nov; 182(11):2671-2674. PubMed ID: 33200910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.